Does ciprofloxacin interact with neutral bilayers? An aspect related to its antimicrobial activity

International Journal of Pharmaceutics

Volumn 252, Issue 1-2, 2003, Pages 149-157

  Hernández Borrell, Jordi ^a   Montero, M Teresa ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

6 Fluoroquinolones; Anisotropy; Fluorescence; Membranes; Monolayers

Indexed keywords

BUFFER; CIPROFLOXACIN; DECANOIC ACID; FLUORESCENT DYE; IODOBENZENE; LIPID; LIPOSOME; PHOSPHOLIPID;

ANISOTROPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BILAYER MEMBRANE; COMPRESSION; DRUG ACTIVITY; DRUG ADSORPTION; DRUG DIFFUSION; DRUG MECHANISM; EPIFLUORESCENCE MICROSCOPY; FLUORESCENCE ANALYSIS; HYDROPHOBICITY; LIPID BILAYER; LIPID MEMBRANE; LIPID MONOLAYER; NONPHOTOCHEMICAL QUENCHING; PH; PHASE TRANSITION; PRIORITY JOURNAL;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPID BILAYERS; LIPOSOMES; MEMBRANES, ARTIFICIAL;

EID: 0037452429     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00633-6     Document Type: Article

References (37)

1. Berlanga M., Ruíz N., Hernández-Borrell J., Montero M.T., Viñas M. Role of the outer membrane in the accumulation of quinolones by Serratia marcescens. Can. J. Micobiol. 46:2000a;716-722.
2. Berlanga M., Vázquez J.L., Hernández-Borrell J., Montero M.T., Viñas M. Evidence of an efflux pump in Serratia marcescens. Microb. Drug Resist. 6:2000;111-117.
3. Chu D.T.W., Fernandes P.B. Structure-activity relationships of the fluoroquinolones. Antimicrob. Agents Chemother. 33:1989;131.
4. Deumié M., El Baraka M.E., Quinones E. Fluorescence quenching of pyrene derivatives by iodide compounds in erythrocyte membranes: an approach of the probe location. J. Photochem. Photobiol. A. 87:1995;105-113.
5. Edsall, J.T., Wyman, J., 1958. Biophysical Chemistry. Academic Press, New York, pp. 496-504.
6. Fallati C.S., Mazzieri M.R., Manzo R.H. Lipophilicity of zwitterionic and non-zwitterionic fluoroquinolone antibacterials. S.T.P. Pharma. Science. 6:1996;162-165.
7. Furet Y.X., Deshusses J., Pechère J.C. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:1992;2506-2511.
8. Grancelli A., Morros A., Cabañas M.E., Domènech Ò., Merino S., Vázquez J.L., Montero M.T., Hernández-Borrell J. The interaction of 6-fluoroquinolones on dipalmitoyl phosphatidylcholine monolayers and liposomes. Langmuir. 18:2002;9177-9182.
9. Hernández-Borrell J., Montero M.T. Calculating microspecies concentration of zwitterion amphoteric compounds: ciprofloxacin as example. J. Chem. Educ. 74:1997;1311-1314.
10. Hooper, D.C., Wolfson, J.S., 1995. Quinolone Antimicrobial Agents, 2nd ed. A.S.M., Whasington, DC.
11. Kaiser R.D., London E. Location of diphenylhexatriene (DPH) and its derivatives within membranes: comparison of different fluorescence quenching analyses of membrane depth. Biochemistry. 37:1998;8180-8190.
12. Klopman G., Wang S., Jacobs M.R., Bajaksouzian S., Edmonds K., Ellner J. Anti-Mycobacterium avium activity of quinolones: in vitro activities. Antimicrob. Agents Chemother. 37:1993;1799-1806.
13. Lakowicz, J.R., 1999. Principles of Fluorescence Spectroscopy, 2nd ed. Kluwer Academic/Plenum Publishers, New York.
14. Majudmar S., Flasher D., Friend D.S., Nassos P., Yajko D., Hadley W.K., Düzgünes N. Efficacies of liposome encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob. Agents Chemother. 36:1992;2808-2815.
15. 1H -NMR study Biochim. Biophys. Acta. 1374:1998;9-20.
16. Merino S., Vázquez J.L., Domènech O., Berlanga M., Viñas M., Montero M.T., Hernández-Borrell J. Fluoroquinolone-biomembrane interaction at the DPPC/PG lipid bilayer interface. Langmuir. 18:2002;3288-3292.
17. Montero M.T., Saiz D., Sitges R., Vázquez J.L., Hernández-Borrell J. Influence of physicochemical properties of fluoroquinolones on encapsulation efficiency in liposomes. Int. J. Pharm. 138:1996;113-120.
18. Montero M.T., Freixas J., Hernández-Borrell J. Expression of the partition coefficients of a homologous series of 6-fluoroquinolones. Int. J. Pharm. 149:1997;161-170.
19. Montero M.T., Hernández-Borrell J., Keough K.M.W. Fluoroquinolone-biomembrane interactions: monolayer and calorimetric studies. Langmuir. 14:1998;2451-2454.
20. Nag K., Boland C., Rich N.H., Keough K.M.W. Design and construction of an epifluorescence microscopic surface balance for the study of lipid monolayer phase transitions. Rev. Sci. Instrum. 61:1990;3425-3430.
21. Nag K., Keough K.M.W., Montero M.T., Trias J., Pons M., Hernández-Borrell J. Evidence of segregation of a quinolone antibiotic in dipalmitoylphosphatidylchilone environment. J. Liposome Res. 64:1996;713-736.
22. Nikaido H., Thanassi D.G. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37:1993;1393-1399.
23. Putman M., van Veeen H.W., Konings W. Molecular properties of bacterial multidrug transporters. Microb. Mol. Biol. Rev. 64:2000;672-693.
24. Ross D.L., Riley C.M. Aqueous solubilities of some variously substituted quinolone antimicrobials. Int. J. Pharm. 63:1990;237-250.
25. Ross D.L., Riley C.M. Physicochemical properties of the fluoroquinolone antimicrobials. II. Acid ionization constants and their relationship to structure. Int. J. Pharm. 83:1992;267-272.
26. Ross D.L., Elkinton S.K., Riley C.M. Physicochemical properties of the fluoroquinolone antimicrobials. III. 1-octanol/water partition coefficients and their relationships to structure. Int. J. Pharm. 88:1992;379-389.
27. Ross D.L., Riley C.M. Physicochemical properties of fluoroquinolone antimicrobials. V. Effect of fluoroquinolone structure and pH on the complexation of various fluoroquinolones with magnesium and calcium ions. Int. J. Pharm. 93:1993a;121-129.
28. Ross D.L., Riley C.M. Physicochemical properties of fluoroquinolone antimicrobials. VI. Effect of metal-ion complexation on octan-1-ol-water partitioning. Int. J. Pharm. 93:1993;131-138.
29. Takács-Novák K., Noszál B., Hermecz I., Kereszturi G., Podanyi B., Szász G. Protonation equilibria of quinolone antibacterials. J. Pharm. Sci. 79:1990;1023-1028.
30. Takács-Novák K., Józan M., Hermecz I., Szász G. Lipophilicity of amphoteric molecules expressed by the true partition coefficient. Int. J. Pharm. 113:1995;47-65.
31. Van Bambeke F., Balzi E., Tulkens P.M. Antibiotic efflux pumps. Biochem. Pharmacol. 60:2000;457-470.
32. Vázquez J.L., Montero M.T., Trias J., Hernández-Borrell J. 6-Fluoroquinolone-liposome interactions: fluorescence quenching study using iodide. Int. J. Pharm. 171:1998;75-86.
33. Vázquez J.L., Merino S., Domènech O., Berlanga M., Viñas M., Montero M.T., Hernández-Borrell J. Determination of the partition coefficients of a homologous series of ciprofloxacin: influence of the N-4 piperazinyl alkylation on the antimicrobial activity. Int. J. Pharm. 220:2001a;53-62.
34. Vázquez J.L., Berlanga M., Merino S., Domènech O., Viñas M., Montero M.T., Hernández-Borrell J. Determination by fluorimetric titration of the ionization constant of ciprofloxacin in solution and in presence of liposomes. Photochem. Photobiol. 73:2001;14-19.
35. Vázquez J.L., Montero M.T., Merino S., Domènech O., Berlanga M., Viñas M., Hernández-Borrell J. Location and nature of the surface membrane binding site of ciprofloxacin: a fluorescence study. Langmuir. 17:2001;1009-1014.
36. Vila J., Ruiz J., Goñi P., Jiménez M.T. Quinolone resistance mutations in the topoisomerase IV pacC gene of Acinetobacter baumanii. J. Antimicrob. Chemother. 39:1997;757-762.
37. Weigel L.M., Steward C.D., Tenover F.C. gyrA Mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42:1998;2661-2667.